OS Therapies (OSTX) Advances Phase 3 Trial Design, Market Pricing Reflects Growth Expectations
· gurufocus.com
On September 15, 2026, OS Therapies Inc (OSTX) announced it has reached full agreement with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA)
On September 15, 2026, OS Therapies Inc OSTX announced it has reached full agreement with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) on...